Agilent | A - Gross Profit On Sales

Stock Price
114.87
Daily Change
-0.75 -0.65%
Monthly
2.55%
Yearly
6.90%
Q2 Forecast
113.08

Agilent reported $946M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Abbott USD 5.86B 675M Mar/2026
Agilent USD 946M 44M Dec/2025
Align Technology USD 683.59M 44.39M Dec/2025
Bio Techne USD 191.28M 3.16M Dec/2025
Bio-Rad Laboratories USD 343.4M 1.9M Sep/2025
Bruker USD 449.2M 69.8M Dec/2025
Charles River Laboratories USD 271.96M 39.43M Dec/2025
Danaher USD 3.59B 375M Mar/2026
Dentsply International USD 443M 2M Dec/2025
Edwards Lifesciences USD 1.29B 59.4M Mar/2026
Henry Schein USD 1.06B 37M Dec/2025
Illumina USD 759M 26M Dec/2025
Intuitive Surgical USD 1.83B 73.8M Mar/2026
IQVIA Holdings USD 1.12B 32M Dec/2025
Laboratory Of America USD 993.2M 31.9M Dec/2025
Mettler Toledo International USD 675.44M 65.98M Dec/2025
Myriad Genetics USD 146.8M 3M Dec/2025
OraSure Technologies USD 11.34M 435K Dec/2025
Quest Diagnostics USD 906M 33M Mar/2026
Quidel USD 274.8M 1.01B Dec/2025
Repligen USD 103.83M 3.32M Dec/2025
Revvity USD 421.66M 47.06M Dec/2025
Roche Holding CHF 22.09B 10.04B Dec/2025
Thermo Fisher Scientific USD 4.49B 146M Mar/2026
Waters USD 557.42M 97.44M Dec/2025
Zimmer Biomet Holdings USD 1.27B 8.1M Dec/2025